Seven year follow-up of the International Randomized Study of Interferon Versus STI571 (IRIS) demonstrates durable efficacy and long-term safety of imatinib in patients (pts) with newly diagnosed chronic myeloid leukaemia in chronic phase (CML-CP)

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): O'Brien SG, Guilhot F, Goldman JM, Hochhaus A, Hughes TP, Radich JP, Rudoltz M, Filian J, Gathmann I, Druker BJ, Larson RA

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: British Journal of Haematology: 49th Annual Scientific Meeting of the British Society for Haematology

Year of Conference: 2009

Pages: 40-41 no. 102

ISSN: 0007-1048

Publisher: Wiley-Blackwell Publishing Ltd.

URL: http://dx.doi.org/10.1111/j.1365-2141.2009.07639.x

DOI: 10.1111/j.1365-2141.2009.07639.x

Library holdings: Search Newcastle University Library for this item

ISBN: 13652141

ePrints